Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Cheng

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Human Vaccines & Immunotherapeutics|May 9, 2023
Hesitancy, reactogenicity and immunogenicity of the mRNA and whole-virus inactivated Covid-19 vaccines in pediatric neuromuscular diseasesMichael Kwan Leung Yu, Sophelia Hoi Shan Chan, Samuel Cheng, et al.
American Heart Journal|April 24, 2012
Safety and efficacy of rescue angioplasty for ST-elevation myocardial infarction with high utilization rates of glycoprotein IIb/IIIa inhibitorsIbrahim M Shugman, Victar Hsieh, Samuel Cheng, et al.
Human Vaccines & Immunotherapeutics|November 14, 2024
Medium-term immunogenicity of three doses of BNT162b2 and CoronaVac in Hong Kong neuromuscular disease patientsMichael Kwan Leung Yu, Sophelia Hoi Shan Chan, Daniel Leung, et al.
Research Square|January 12, 2022
Neutralizing antibody titres to SARS-CoV-2 Omicron variant and wild-type virus in those with past infection or vaccinated or boosted with mRNA BNT162b2 or inactivated CoronaVac vaccinesMalik Peiris, Samuel Cheng, Chris Ka Pun Mok, et al.
Journal of Virology|February 26, 2005
B-cell responses in patients who have recovered from severe acute respiratory syndrome target a dominant site in the S2 domain of the surface spike glycoproteinXiaofen Zhong, Huanghao Yang, Zu-Feng Guo, et al.
Annals of the Academy of Medicine, Singapore|June 26, 2024
Frailty-aware surgical care: Validation of Hospital Frailty Risk Score (HFRS) in older surgical patientsChristine Shi Min Chau, Samuel Cheng En Ee, Xiaoting Huang, et al.
Kidney International|March 1, 2022
Antibody responses to 2 doses of mRNA COVID-19 vaccine in pediatric patients with kidney diseasesAlison Lap-Tak Ma, Daniel Leung, Eugene Yu-Hin Chan, et al.
Asia-Pacific Journal of Clinical Oncology|November 19, 2019
What is the value of third-line chemotherapy in advanced gastroesophageal cancer? A 5-year retrospective analysis at a single centerJustina Yick Ching Lam, Su Pin Choo, David Wai-Meng Tai, et al.
Journal of Virology|May 14, 2004
T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARSYue-Dan Wang, Wan-Yee Fion Sin, Guo-Bing Xu, et al.
Asian Journal of Psychiatry|June 25, 2025
Perspectives on psychotherapy in Southeast Asia: Insights from psychiatrists and trainees (Part I: Attitudes, current practices and training preferences)Warut Aunjitsakul, Kanthee Anantapong, Nisan Werachattawan, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Human Vaccines & Immunotherapeutics|May 9, 2023
Hesitancy, reactogenicity and immunogenicity of the mRNA and whole-virus inactivated Covid-19 vaccines in pediatric neuromuscular diseasesMichael Kwan Leung Yu, Sophelia Hoi Shan Chan, Samuel Cheng, et al.
American Heart Journal|April 24, 2012
Safety and efficacy of rescue angioplasty for ST-elevation myocardial infarction with high utilization rates of glycoprotein IIb/IIIa inhibitorsIbrahim M Shugman, Victar Hsieh, Samuel Cheng, et al.
Human Vaccines & Immunotherapeutics|November 14, 2024
Medium-term immunogenicity of three doses of BNT162b2 and CoronaVac in Hong Kong neuromuscular disease patientsMichael Kwan Leung Yu, Sophelia Hoi Shan Chan, Daniel Leung, et al.
Research Square|January 12, 2022
Neutralizing antibody titres to SARS-CoV-2 Omicron variant and wild-type virus in those with past infection or vaccinated or boosted with mRNA BNT162b2 or inactivated CoronaVac vaccinesMalik Peiris, Samuel Cheng, Chris Ka Pun Mok, et al.
Journal of Virology|February 26, 2005
B-cell responses in patients who have recovered from severe acute respiratory syndrome target a dominant site in the S2 domain of the surface spike glycoproteinXiaofen Zhong, Huanghao Yang, Zu-Feng Guo, et al.
Annals of the Academy of Medicine, Singapore|June 26, 2024
Frailty-aware surgical care: Validation of Hospital Frailty Risk Score (HFRS) in older surgical patientsChristine Shi Min Chau, Samuel Cheng En Ee, Xiaoting Huang, et al.
Kidney International|March 1, 2022
Antibody responses to 2 doses of mRNA COVID-19 vaccine in pediatric patients with kidney diseasesAlison Lap-Tak Ma, Daniel Leung, Eugene Yu-Hin Chan, et al.
Asia-Pacific Journal of Clinical Oncology|November 19, 2019
What is the value of third-line chemotherapy in advanced gastroesophageal cancer? A 5-year retrospective analysis at a single centerJustina Yick Ching Lam, Su Pin Choo, David Wai-Meng Tai, et al.
Journal of Virology|May 14, 2004
T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARSYue-Dan Wang, Wan-Yee Fion Sin, Guo-Bing Xu, et al.
Asian Journal of Psychiatry|June 25, 2025
Perspectives on psychotherapy in Southeast Asia: Insights from psychiatrists and trainees (Part I: Attitudes, current practices and training preferences)Warut Aunjitsakul, Kanthee Anantapong, Nisan Werachattawan, et al.
Pageof 7